In addition, mutation of the ADAMTS13 gene, marked cytokinemia, enhanced endotoxemia and/or the presence of protease inhibitors may be closely related to declining ADAMTS13: AC14,17. Here, ADAMTS13 is linked to serum lipopolysaccharide activity.